Last updated: 5 September 2024 at 4:54pm EST

Kevin Lee Freeman Net Worth




The estimated Net Worth of Kevin Lee Freeman is at least $2.14 Million dollars as of 3 September 2024. Kevin Freeman owns over 7,500 units of Health Catalyst Inc stock worth over $2,034,254 and over the last 2 years Kevin sold HCAT stock worth over $103,125.

Kevin Freeman HCAT stock SEC Form 4 insiders trading

Kevin has made over 2 trades of the Health Catalyst Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Kevin sold 7,500 units of HCAT stock worth $54,150 on 3 September 2024.

The largest trade Kevin's ever made was selling 7,500 units of Health Catalyst Inc stock on 3 September 2024 worth over $54,150. On average, Kevin trades about 1,364 units every 8 days since 2022. As of 3 September 2024 Kevin still owns at least 255,881 units of Health Catalyst Inc stock.

You can see the complete history of Kevin Freeman stock trades at the bottom of the page.



What's Kevin Freeman's mailing address?

Kevin's mailing address filed with the SEC is C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN, UT, 84095.

Insiders trading at Health Catalyst Inc

Over the last 5 years, insiders at Health Catalyst Inc have traded over $32,461,176 worth of Health Catalyst Inc stock and bought 554,600 units worth $5,926,241 . The most active insiders traders include Daniel D. Burton, Mark B Templeton und Paul Horstmeier. On average, Health Catalyst Inc executives and independent directors trade stock every 8 days with the average trade being worth of $135,905. The most recent stock trade was executed by Benjamin Landry on 6 September 2024, trading 2,466 units of HCAT stock currently worth $18,224.



What does Health Catalyst Inc do?

health catalyst is dedicated to enabling health care organizations to fundamentally improve care by building the most comprehensive and fully integrated suite of healthcare data warehousing and process improvement solutions available. health catalyst was formed by a group of healthcare veterans with vast data warehousing and quality improvement experience. our founders and executives collaborated for nearly a decade to revolutionize clinical process models using analytics. during development, they faced numerous hurdles in the quest to develop a data warehouse that could handle the complexities unique to healthcare data. after determining that the predominant approaches to data modeling weren’t effective for healthcare data, they discovered the solution, which is now known as the adaptive data architecture. using a late-binding bus architecture, catalyst’s adaptive data model is agile, flexible, and can be implemented in a matter of weeks compared to the months or years traditional app



What does Health Catalyst Inc's logo look like?

Health Catalyst Inc logo

Complete history of Kevin Freeman stock trades at Health Catalyst Inc

Datum
#
Unternehmen
Insider
Trans.
Transaktion
Anzahl der Aktien Preis je Aktie Gesamtpreis Anzahl der Aktien nach Quelle
3 Sep 2024 Kevin Lee Freeman
Chief Commercial Officer
Verkauf 7,500 $7.22 $54,150
3 Sep 2024
255,881
11 Jun 2024 Kevin Lee Freeman
Chief Commercial Officer
Verkauf 7,500 $6.53 $48,975
11 Jun 2024
266,153


Health Catalyst Inc executives and stock owners

Health Catalyst Inc executives and other stock owners filed with the SEC include: